Fenticonazole activity in transfected cells
Cell-based study · cos-7 cells [1]
Transfected cos-7 cells were treated with Fenticonazole, with DMSO as the negative control. Fenticonazole exhibited weak PPARγ agonistic activity compared with DMSO, assessed using luciferase activity normalized to renilla activity.
| Endpoint | Reported result | Reference |
|---|---|---|
| The luciferase activity was normalized to renilla activity. | Reported result At a concentration of 30 or 100 μM for another 24 h: podophyllotoxone exhibited weak PPARγ agonistic activity, similar to fenticonazole (FN). | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 30 or 100 μM
- Exposure duration
- After 24 h of incubation, the transfected cells were treated with DMSO, podophyllotoxone, FN and Rosi at a concentration of 30 or 100 μM for another 24 h.
- Method
- the transfected cells were treated
- Co-treatment
- Other interventions in this design: hPPARγ; PPRE × 3 TK-luciferase plasmids; renilla luciferase plasmids. Compound effect isolated by the comparison: compared with DMSO group.
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Fenticonazole
The paper names Fenticonazole without stating the salt or form; not verified as the nitrate form supplied as A11852. No dose conversion or lot validation.
2. Results > 2.5. TR-FRET Competitive Binding Assay and PPARγ Transactivation Assay (S91); 3. Materials and Methods > 3.5. Materials (S128); 3. Materials and Methods > 3.7. PPARγ Transactivation Assay (S142, S143, S145, S146, S147); Figure 4 legend (S156)
The luciferase activity was normalized to renilla activity.: The luciferase activity was normalized to renilla activity.; comparator: DMSO serving as the negative control and rosiglitazone (Rosi) serving as the positive control — 2. Results > 2.5. TR-FRET Competitive Binding Assay and PPARγ Transactivation Assay (S91); 3. Materials and Methods > 3.7. PPARγ Transactivation Assay (S143, S146)